{
    "startDate": "2019-01-01",
    "endDate": "2019-03-31",
    "year": "2019",
    "quarter": "Q1",
    "symbol": "AVEO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 23483000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 2571000
            },
            {
                "label": "Clinical trial retainers current.",
                "concept": "aveo:ClinicalTrialRetainersCurrent",
                "unit": "usd",
                "value": 42000
            },
            {
                "label": "Other prepaid expenses and other assets current.",
                "concept": "aveo:OtherPrepaidExpensesAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 199000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 26295000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 212000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 26507000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 2109000
            },
            {
                "label": "Accrued clinical trial costs and contract research current.",
                "concept": "aveo:AccruedClinicalTrialCostsAndContractResearchCurrent",
                "unit": "usd",
                "value": 6352000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2132000
            },
            {
                "label": "Loans payable, net of discount",
                "concept": "LoansPayableCurrent",
                "unit": "usd",
                "value": 5688000
            },
            {
                "label": "Deferred revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 1974000
            },
            {
                "label": "Deferred research and development reimbursement current.",
                "concept": "aveo:DeferredResearchAndDevelopmentReimbursementCurrent",
                "unit": "usd",
                "value": 336000
            },
            {
                "label": "Other liabilities (Note 6)",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 300000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 18891000
            },
            {
                "label": "Loans payable, net of current portion and discount",
                "concept": "LongTermLoansPayable",
                "unit": "usd",
                "value": 13511000
            },
            {
                "label": "Deferred revenue",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 4032000
            },
            {
                "label": "PIPE Warrant liability (Note 7)",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 7859000
            },
            {
                "label": "Other liabilities (Note 6)",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 790000
            },
            {
                "label": "Liabilities and stockholders\u2019 deficit",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 45083000
            },
            {
                "label": "Preferred stock, $.001 par value: 5,000 shares authorized at March 31, 2019 and December 31, 2018; no shares issued and outstanding at each of March 31, 2019 and December 31, 2018",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $.001 par value: 250,000 shares authorized at March 31, 2019 and December 31, 2018; 139,000 and 126,485 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 139000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 575738000
            },
            {
                "label": "Accumulated other comprehensive income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -594454000
            },
            {
                "label": "Stockholders\u2019 deficit:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -18576000
            },
            {
                "label": "Liabilities and stockholders\u2019 deficit",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 26507000
            }
        ],
        "cf": [
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 555000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 584000
            },
            {
                "label": "Non-cash interest expense",
                "concept": "PaidInKindInterest",
                "unit": "usd",
                "value": 166000
            },
            {
                "label": "Non-cash change in fair value of PIPE Warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": -8815000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -455000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -241000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -1390000
            },
            {
                "label": "Increase decrease in accrued contract research.",
                "concept": "aveo:IncreaseDecreaseInAccruedContractResearch",
                "unit": "usd",
                "value": 98000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": -778000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 546000
            },
            {
                "label": "Increase decrease in deferred research and development reimbursement.",
                "concept": "aveo:IncreaseDecreaseInDeferredResearchAndDevelopmentReimbursement",
                "unit": "usd",
                "value": -118000
            },
            {
                "label": "Operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -8456000
            },
            {
                "label": "Proceeds from issuance of common stock, net of issuance costs",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 7512000
            },
            {
                "label": "Financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 7512000
            },
            {
                "label": "Net (decrease) increase in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": -944000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 507000
            },
            {
                "label": "Deferred offering costs accrued.",
                "concept": "aveo:DeferredOfferingCostsAccrued",
                "unit": "usd",
                "value": 212000
            }
        ],
        "ic": [
            {
                "label": "Revenues",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 1611000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 6852000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2455000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 9307000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -7696000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 564000
            },
            {
                "label": "Change in fair value of PIPE Warrant liability",
                "concept": "AdjustmentOfWarrantsGrantedForServices",
                "unit": "usd",
                "value": -8815000
            },
            {
                "label": "Other income (expense), net:",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 8251000
            },
            {
                "label": "Net income (loss)",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 555000
            },
            {
                "label": "Basic net income (loss) per share",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 0.01
            },
            {
                "label": "Weighted average number of common shares outstanding",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 132304000
            },
            {
                "label": "Diluted net income (loss) per share",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -0.06
            },
            {
                "label": "Weighted average number of common shares and dilutive common share equivalents outstanding",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 132831000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 555000
            }
        ]
    }
}